All lobbying filings

JOHNSON & JOHNSON SERVICES, INC.

JOHNSON & JOHNSON SERVICES, INC. filed a Q4 report for JOHNSON & JOHNSON SERVICES INC on January 20, 2026.

Lobbying for JOHNSON & JOHNSON SERVICES INC

All filings by JOHNSON & JOHNSON SERVICES, INC. · Everything JOHNSON & JOHNSON SERVICES INC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$1,510,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 9

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6167, the Health Tech Investment Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing

Budget/Appropriations

- Issues related to stroke care

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property - patent thickets - patent fees

Law Enforcement/Crime/Criminal Justice

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

Pharmacy

- Issues related to the SUPPORT Act

Science/Technology

Issues related to - artificial intelligence - data privacy - cybersecurity - robotics

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax

Veterans

Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce

Trade (domestic/foreign)

- Issues related to USMCA review and renegotiation

Bills named in this filing 26

H.R. 1539
Medical Device Electronic Labeling Act
H.R. 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
S. 266
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
H.R. 946
ORPHAN Cures Act
S. 864
HELP Copays Act
H.R. 2214
DRUG Act
H.R. 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S. 832
EPIC Act of 2025
S. 1954
Biosimilar Red Tape Elimination Act
H.R. 5526
Biosimilar Red Tape Elimination Act
H.R. 2527
Early Detection of Vision Impairments for Children Act of 2025
H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
H.R. 4282
Contact Lens Prescription Verification Modernization Act
H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act
S. 1399
Health Tech Investment Act
H.R. 6167
HEALTH Act of 2025
H. Res. 1301
Expressing support for the inaugural Heart Recovery Awareness Day on February 20, 2025.
S. 1040
Drug Competition Enhancement Act
S. 1041
Affordable Prescriptions for Patients Act
S. 1097
Interagency Patent Coordination and Improvement Act of 2025
H.R. 3269
ETHIC Act
S. 2276
ETHIC Act
S. 2658
Medication Affordability and Patent Integrity Act

Show all 26 bills

H.R. 1109
Litigation Transparency Act of 2025
H.R. 2675
Protecting Our Courts from Foreign Manipulation Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.